Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AVBP
COLL
Add up to 3 more stocks
AVBP
ArriVent BioPharma, Inc.
-48.56%
$14.64-13.82Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$681.86M
52W Range
$17.00 - $35.83
COLL
Collegium Pharmaceutical, Inc.
+0.69%
$22.02+0.15Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$714.19M
52W Range
$21.43 - $50.79
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 17.76 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 0.99 |
| P/B Ratio | 1.86 | 2.29 |
| P/S Ratio | N/A | 0.88 |
| P/FCF Ratio | N/A | 2.18 |
| EV/EBITDA | N/A | 2.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 60.0% |
| Operating Margin | 0.0% | 19.6% |
| Net Margin | 0.0% | 5.9% |
| ROE | -44.6% | 15.4% |
| ROA | -41.5% | 2.2% |
| ROIC | -48.0% | 6.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 14.16 | 1.03 |
| Quick Ratio | 14.16 | 0.84 |
| Debt/Equity | 0.00 | 2.75 |
| Interest Coverage | N/A | 2.27 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.